On June 26, 2002, the state of Arizona embarked on an exciting effort to transform its economy and revolutionize healthcare when then-Governor Jane Hull announced the creation of the Translational Genomics Research Institute. Today, TGen celebrates how far we have come: Delivering earlier diagnoses and smarter treatments based on a patient’s DNA blueprint. Click on the infographic above to learn about some of our past achievements, and watch the videos below to see where we’re headed in our cancer and neurological research.Continue reading
Category Archives: AZBio News
Quest to Prevent Macular Degeneration Continues With UA Researcher’s $1.7M NIH Grant
After showing that individuals who take levodopa, or l-dopa, for movement disorders such as Parkinson’s disease are protected from developing macular degeneration, University of Arizona researcher Brian S. McKay, PhD, is taking the next step in his quest to prevent the blinding eye disease, thanks to a $1.7 million R01 grant from the National Eye Institute of the National Institutes of Health.
UA College of Medicine Phoenix Receives Full Accreditation
After successfully navigating the accreditation process that began six years ago, the UA College of Medicine – Phoenix has been granted full accreditation by the Liaison Committee on Medical Education (LCME).Continue reading
SenesTech Launches Second Manufacturing Line in Flagstaff to Ensure Uninterrupted Supply
FLAGSTAFF, Ariz., June 13, 2017 — SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that in an effort to ensure that the Company can meet the rapidly increasing demand for their innovative new rodent control technology, ContraPest, it has launched its second manufacturing line in Flagstaff. With the addition of this second line, the Company’s existing manufacturing capacity is expected to more than double.
C-PATH and CDISC Announce Public Review Period for Duchenne Therapeutic Area Standard
The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the availability of a Duchenne muscular dystrophy therapeutic area user guide (TAUG-DMD v1.0) for public review. The review period for the TAUG-DMD v1.0 began on May 8, 2017, and runs through July 6, 2017. Qualified researchers and clinicians are encouraged to review TAUG-DMD v1.0 and offer feedback.Continue reading
ASU engineer working to develop disposable point-of-care sensor
The project aims to develop a disposable, point-of-care biosensor for rapid diagnosis and health monitoring, supported by a four-year, $1.8 million Smart and Connected Health award from the National Science Foundation.Continue reading
VisionGate Hires Prominent Pathologist as Medical Director
Former Massachusetts General Hospital’s Dr. David Wilbur To Oversee VisionGate’s CLIA laboratory. VisionGate’s ground-breaking technology can help eradicate not only the world’s deadliest disease – lung cancer — but other cancers as well.